Hippocampal injections of amyloid β-peptide 1-40 impair subsequent one-trial/day reward learning

Neurobiology of Learning and Memory

Volumn 76, Issue 2, 2001, Pages 125-137

  Malin, David H ^a   Crothers, Marie K ^a   Lake, J Ronald ^a   Goyarzu, Pilar ^a   Plotner, Robert E ^a   Garcia, Sergio A ^a   Spell, Stacy H ^a   Tomsic, Beverly J ^a   Giordano, Tony ^b   Kowall, Neil W ^c,d  

^a UNIVERSITY OF HOUSTON   (United States)

^b Message Pharmaceuticals Inc   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid peptides; Hippocampus; Memory impairment; Neurodegeneration; Rat; Reward learning

Indexed keywords

AMYLOID BETA PROTEIN; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FOOD DEPRIVATION; GLIOSIS; HIPPOCAMPUS; HISTOPATHOLOGY; INJECTION SITE; LEARNING; MALE; NERVE CELL LESION; NONHUMAN; RAT; REWARD;

EID: 17944379098     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1006/nlme.2000.3991     Document Type: Article

References (46)

1. Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo
2. The cholinergic hypothesis of geriatric memory dysfunction
3. Neuropathological staging of Alzheimer-related changes
4. Toxicity of β-amyloid 25-35 peptide in PC12 cells
5. Implants containing β-amyloid protein are not neurotoxic to young and old rat brain
6. Multimodal amnesic syndrome following bilateral temporal and basal forebrain damage
7. Bilateral injections of βA(25-35)+IBO into the hippocampus disrupts acquisition of spatial learning in the rat
8. Hippocampal representation in place learning
9. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain
10. Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease
11. Effects of injected Alzheimer β-amyloid cores in rat brain
12. Lack of Alzheimer pathology after β-amyloid protein injections in rat brain
13. Similarities between β amyloid peptides 1-40 and 40-1: Effects on aggregation, toxicity in vitro, and injection in young and aged rats
14. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis
15. β-Amyloid increases cathepsin D levels in hippocampus
16. Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release
17. Memory-related neural systems in Alzheimer's disease: An anatomic study
18. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excito-toxic damage
19. β-amyloid peptides induce degeneration of cultured rat microglia
20. An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P
21. In vivo toxicity of β-amyloid and the β(25-35) fragment
22. Monkeys with combined amygdalo-hippocampal lesions succeed in object discrimination learning despite 24-hour intervals
23. Methanesulfonyl fluoride enhances one-trial reward learning in mid-aged rats
24. Galanin attenuates retention of one-trial reward learning
25. Chronic methanesulfonyl fluoride enhances one-trial per day reward learning in aged rats
26. Effect of β-amyloid peptides on neurons in hippocampal slice cultures
27. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
28. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF
29. Effects of an exogenous β-amyloid peptide on retention for spatial learning
30. The neurotoxicity of amyloid β protein in aged primates
31. β-Amyloid protein-induced Alzheimer's Disease animal model
32. β-amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimer pathology
33. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
34. Synthetic amyloid β-protein falls to produce specific toxicity in monkey cerebral cortex
35. Dissociation between components of spatial memory in rats after recovery from the effects of retrohippocampal lesions
36. Alzheimer's Disease: A central role for amyloid
37. In vitro and in vivo models to unravel the potential roles of β/A4 in the pathogenesis of Alzheimer's disease
38. Failure of β-amyloid protein fragment 25-35 to cause hippocampal damage in the rat
39. Toxic effect of β-amyloid peptide (β 22-35) on the hippocampal neuron and its prevention
40. Administration of amyloid β-peptides in the rat medial septum cause memory deficits: Reversal by SR 57746A, a non-peptide neurotrophic compound
41. Solvent effects on β protein toxicity in vivo
42. Fimbriafornix lesions impair spatial working memory but not cognitive mapping
43. Calcium channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture
44. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides
45. Human amnesia in the medial temporal region: Memory impairment following a bilateral lesion limited to the CA1 field of the hippocampus